2011年-世界发展银行全球_Private_Sector_Pharmaceutical_Supply_and_Distribution_Channels_in_Africa___A_Focus_on_Ghana_Malawi_and_Mali_78页_1mb

Summary of Private Sector Pharmaceutical Supply and Distribution Channels in Africa: A Focus on Ghana, Malawi and Mali

Core Content

This document analyzes the private sector pharmaceutical supply and distribution channels in three African countries: Ghana, Malawi, and Mali, as part of the World Bank's Health, Nutrition, and Population (HNP) Discussion Paper Series. The study aims to understand the state of these channels, identify performance gaps, and suggest ways to reinforce the private sector to improve access to high-quality medicines.

---

Main Points

Importance of Private Sector in Pharmaceutical Supply

• The private sector plays a critical role in providing medicines in Africa, especially in countries where public health systems are underdeveloped or unable to meet demand.
• It serves both formal and informal markets, offering alternatives to public sector supply when it is inadequate, unaffordable, or of poor quality.
• In some cases, the private sector is the only viable option for patients, particularly the poor, who often resort to informal channels due to affordability and availability issues.

Key Challenges

• Poor supply chain management: Inadequate forecasting, storage, and logistics contribute to chronic stockouts.
• Stock pilfering: Theft and mismanagement of medicines are significant issues in all three countries.
• Insufficient human resources: Limited availability of trained personnel affects the quality and reliability of pharmaceutical services.
• Limited financing: Both public and private sectors face challenges in funding, especially in resource-poor settings.
• Informal sector growth: The informal market is expanding, driven by poverty, lack of education, and high costs in the formal sector. Products in this sector may be counterfeit or substandard, posing risks to patients.

Role of the State

• The state is a major purchaser and supplier of medicines in all three countries.
• Ghana and Malawi have more developed private sectors, while Mali has no local pharmaceutical manufacturing.
• In Malawi, the government heavily relies on imports, and the public sector controls most procurement through the Central Medical Store (CMS), with limited involvement of the private sector.
• In Ghana, the government restricts the import of 44 basic medicines, promoting local manufacturing, and the National Health Insurance Scheme (NHIS) has increased demand for medicines, leading to a shift from public to private supply.

---

Country Context

Ghana

• Economic Status: Higher per capita income than Malawi and Mali.
• Health Services: Public and private sectors both provide services. NHIS covers a significant portion of the population.
• Pharmaceutical Market: Has 32 manufacturers, with 22 active. Local manufacturers supply 30% of the market.
• Regulation: Strong regulatory framework, with exemptions on taxes for essential materials.

Malawi

• Economic Status: Lower per capita income compared to Ghana and Mali.
• Health Services: Public sector provides free services and medicines, but with some out-of-pocket costs. Private sector is underdeveloped.
• Pharmaceutical Market: No local manufacturing. Relies heavily on imports. CMS dominates procurement.
• Regulation: Limited, with a growing informal sector.

Mali

• Economic Status: Lowest per capita income of the three.
• Health Services: Public sector provides services with small co-payments. Private sector is limited.
• Pharmaceutical Market: No local manufacturing. CMS is the main supplier for the public sector.
• Regulation: Government contracts CMS for procurement and distribution, but informal channels are also expanding.

---

Performance of Private Supply and Distribution Channels

• Geographic Access: The private sector improves access in rural areas where public infrastructure is lacking.
• Availability: Chronic stockouts in the public sector drive demand for private and informal channels.
• Quality and Affordability: Concerns about counterfeit and substandard products persist, but the private sector often offers more affordable options.

---

Recommendations for Strengthening the Private Sector

• Choosing a Model That Works in a Specific Context: Tailor approaches to local conditions and market structures.
• Supporting Private Supply Channels:
  • Business and Investors: Encourage investment in pharmaceutical manufacturing and distribution.
  • National Governments: Improve regulatory frameworks, support local businesses, and ensure timely payments to private suppliers.
  • International Agencies: Provide technical and financial support to enhance private sector capabilities.

---

Key Findings

• The private sector is increasingly important in African health systems, especially in resource-poor settings.
• Informal channels are growing due to affordability and availability issues, but they pose risks to patient safety.
• Donor funding can influence the private sector by supporting alternative procurement and distribution models.
• There is a need for better coordination, regulation, and investment to enhance the performance and reliability of private pharmaceutical supply chains.

---

Conclusion

This study highlights the complex role of the private sector in pharmaceutical supply and distribution across Ghana, Malawi, and Mali. It underscores the importance of strengthening these channels to ensure sustainable access to affordable, high-quality medicines, especially in the context of underdeveloped public health systems. The findings suggest that a combination of policy reforms, investment, and improved business environments could enhance the effectiveness of private sector involvement in pharmaceutical supply.